Department of Medicine Archive — Page 5 of 120
-
December 10, 2025
Sedative choice could improve outcomes for breathing tube patients
It's the first study to demonstrate cardiovascular risks of high doses of ketamine (low blood pressure, arrhythmia), side effects that have not been well studied in the past. -
December 8, 2025
Interim data reported for multiple myeloma off-the-shelf CAR-T therapy
Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells. -
December 4, 2025
Vanderbilt-Ingram researchers present cancer advancements at ASH 2025
Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. -
December 3, 2025
Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics
A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects. -
December 2, 2025
Ketamine fails surgical recovery trial
In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery. -
December 1, 2025
Timothy Sterling receives $5.7 million to study tuberculosis transmission
Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission. -
November 26, 2025
Protein plays dual roles in repairing damaged kidney
These findings were unexpected and demonstrate that the actin cytoskeleton repairs cell organelles like mitochondria in a regulated way.